SEARCH

SEARCH BY CITATION

References

  • Benkerrou, M., Jais, J.P., Leblond, V., Durandy, A., Sutton, L., Bordigoni, P., Garnier, J.L., Le Bidois, J., Le Deist, F., Blanche, S., Fischer, A. (1998) Anti-B cell monoclonal antibody treatment of severe post transplant B-lymphoproliferative disorder: prognostic factors and long term outcome. Blood, 92, 31373147.
  • Curtis, R.E., Travis, L.B., Rowlings, P.A., Socie, G., Kingma, D.W., Banks, P.M., Jaffe, E.S., Sale, G.E., Horowitz, M.M., Witherspoon, R.P., Shriner, D.A., Weisdorf, D.J., Kolb, H.J., Sullivan, K.M., Sobocinski, K.A., Gale, R.P., Hoover, R.N., Fraumeni, Jr, J.F., Deeg, H.J. (1999) Risk of lymphoproliferative disorders after stem cell transplantation: a multi-institutional study. Blood, 94, 22082216.
  • Faye, A., Van Den Abeele, T., Peuchmaur, M., Mathieu-Boue, A., Vilmer, E. (1998) Anti-CD20 monoclonal antibody for post-transplant lymphoproliferative disorders. Lancet, 352, 1285.
  • Fischer, A., Landais, P., Friedrich, W., Gerritsen, B., Fasth, A., Porta, F., Vellodi, A., Benkerrou, M., Jais, J.P., Cavazzana-Calvo, M. (1994) Bone marrow transplantation in Europe for primary immunodeficiencies other than severe combined immunodeficiency: an ESCT/EGID report. Blood, 83, 11491154.
  • Glucksberg, H., Storb, R., Fefer, A., Buckner, C.D., Neiman, P.E., Clift, R.A., Lerner, K.G., Thomas, E.D. (1974) Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation, 18, 295304.
  • Kuehnle, I., Huls, M.H., Liu, Z., Semmelmann, M., Krance, R.A., Brenner, M.K., Rooney, C.M., Heslop, H.E. (2000) CD20 monoclonal antibody (rituximab) for therapy of Epstein-Barr virus lymphoma after hemopoietic stem-cell transplantation. Blood, 95, 15021505.
  • Malatack, J.F., Gartner, Jr, J.C., Urbach, A.H., Zitelli, B.J. (1991) Orthotopic liver transplantation, Epstein-Barr virus, cyclosporine, and lymphoproliferative disease: a growing concern. Journal of Pediatrics, 118, 667675.
  • Maloney, D.G., Smith, B., Appelbaum, F. (1996) The anti-tumor effect of monoclonal anti-CD20 antibody (MAB) therapy includes direct anti-proliferative activity and induction of apoptosis in CD20 positive non Hodgkin's lymphoma (NHL) cell lines. Blood, 88, 637a.
  • Maloney, D.G., Grillo-Lopez, A.J., White, C.A., Bodkin, D., Schilder, R.J., Neidhart, J.A., Janakiraman, N., Foon, K.A., Liles, T.M., Dallaire, B.K., Wey, K., Royston, I., Davis, T., Levy, R. (1997) IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-low grade non Hodgkin's lymphoma. Blood, 90, 21882195.
  • Milpied, N., Vasseur, B., Parquet, N., Garnier, J.L., Antoine, C., Quartier, P., Carret, A.S., Bouscary, D., Faye, A., Bourbigot, B., Reguerre, Y., Stoppa, A.M., Bourquard, P., De Hurault Ligny, B., Dubief, F., Mathieu-Boue, A., Leblond, V. (2000) Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: a retrospective analysis on 32 patients. Annals of Oncology, 2000, 11, S113–S116.
  • Nalesnik, M.A., Jaffe, R., Starzl, T.E., Demetris, A.J., Porter, K., Burnham, J.A., Makowka, L., Ho, M., Locker, J. (1988) The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporin A-prednisone immunosuppression. American Journal of Pathology, 133, 173192.
  • Papadopoulos, E.B., Ladanyi, M., Emanuel, D., Mackinnon, S., Boulad, F., Carabasi, M.H., Castro-Malaspina, H., Childs, B.H., Gillio, A.P., Small, T.N. (1994) Infusion of donor leucocytes to treat Epstein-Barr Virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. New England Journal of Medicine, 330, 11851191.
  • Rooney, C.M., Smith, C.A., Ng, C.Y., Loftin, S., Li, C., Krance, R.A., Brenner, M.K., Heslop, H.E. (1995) Use of gene modified virus-specific T lymphocytes to control Epstein-Barr virus-related lymphoproliferation. Lancet, 345, 913.
  • Shapiro, R.S., McClain, K., Frizzera, G., Gajl-Peczalska, K.J., Kersey, J.H., Blazar, B.R., Arthur, D.C., Patton, D.F., Greenberg, J.S., Burke, B. (1988) Epstein-Barr Virus associated B cell lymphoproliferative disorders following bone marrow transplantation. Blood, 71, 12341243.
  • Socie, G., Curtis, R.E., Deeg, H.J., Sobocinski, K.A., Filipovich A.H., Travis, L.B., Sullivan, K.M., Rowlings, P.A., Kingma, D.W., Banks, P.M., Travis, W.D., Witherspoon, R.P., Sanders, J., Jaffe, E.S., Horowitz, M.M. (2000) New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia. Journal of Clinical Oncology, 18, 348357.
  • Starzl, T.E., Nalesnik, M.A., Porter, K.A., Ho, M., Iwatsuki, S., Griffith, B.P., Rosenthal, J.T., Hakala, T.R., Shaw, Jr, B.W., Hardesty, R.L. (1984) Reversibility of lymphoma and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet, 1, 583587.
  • Yang, J., Tao, Q., Flinn, I.W., Murray, P.G., Post, L.E., Ma, H., Piantadosi, S., Caligiuri, M.A., Ambinder, R.F. (2000) Characterization of Epstein-barr virus-infected cells in patients with post transplantation lymphoproliferative disease: disappearance after rituximab therapy does not predict clinical response. Blood, 96, 40554063.
  • Zutter, M.M., Martin, P.J., Sale, G.E., Shulman, H.M., Fisher, L., Thomas, E.D., Durnam, D.M. (1988) Epstein-Barr virus lymphoproliferation after blood marrow transplantation. Blood, 72, 520529.